| 前收盘价格 | 396.37 |
| 收盘价格 | 396.72 |
| 成交量 | 367,881 |
| 平均成交量 (3个月) | 666,845 |
| 市值 | 23,504,910,336 |
| 市盈率 (P/E TTM) | 36.22 |
| 预期市盈率 (P/E Forward) | 28.01 |
| 价格/销量 (P/S) | 7.65 |
| 股市价格/股市净资产 (P/B) | 10.16 |
| 52周波幅 | |
| 利润日期 | 4 Nov 2025 |
| 营业毛利率 | 22.02% |
| 营业利益率 (TTM) | 22.93% |
| 稀释每股收益 (EPS TTM) | 11.01 |
| 季度收入增长率 (YOY) | 3.90% |
| 季度盈利增长率 (YOY) | 18.80% |
| 总债务/股东权益 (D/E MRQ) | 78.58% |
| 流动比率 (MRQ) | 1.81 |
| 营业现金流 (OCF TTM) | 758.81 M |
| 杠杆自由现金流 (LFCF TTM) | 588.83 M |
| 资产报酬率 (ROA TTM) | 11.61% |
| 股东权益报酬率 (ROE TTM) | 40.82% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 看涨 | 混合的 |
| Diagnostics & Research (全球的) | 看涨 | 混合的 | |
| 股票 | Waters Corporation | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | -1.5 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 1.13 |
|
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Mid Core |
| 内部持股比例 | 0.16% |
| 机构持股比例 | 98.23% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Fundsmith Llp | 30 Sep 2025 | 3,955,498 |
| Mawer Investment Management Ltd. | 30 Sep 2025 | 1,551,010 |
| Fundsmith Investment Services Ltd. | 30 Sep 2025 | 1,356,289 |
| Ako Capital Llp | 30 Sep 2025 | 806,948 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 423.00 (Morgan Stanley, 7.14%) | 保留 |
| 中 | 390.00 (-1.22%) | |
| 低 | 325.00 (JP Morgan, -17.68%) | 保留 |
| 平均值 | 382.60 (-3.09%) | |
| 总计 | 1 购买, 4 保留 | |
| 平均价格@调整类型 | 360.13 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Morgan Stanley | 02 Dec 2025 | 423.00 (7.14%) | 保留 | 398.62 |
| TD Cowen | 05 Nov 2025 | 390.00 (-1.22%) | 保留 | 371.97 |
| Wells Fargo | 05 Nov 2025 | 385.00 (-2.48%) | 保留 | 371.97 |
| JP Morgan | 09 Oct 2025 | 325.00 (-17.68%) | 保留 | 330.45 |
| Rothschild & Co | 08 Oct 2025 | 390.00 (-1.22%) | 购买 | 327.65 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合